Max Hodak’s Science raises $400m to take its sight-restoring chip to the US

The Series D values the brain-computer interface company at $3.5bn, TechCrunch reports. Science will use it to expand PRIMA across Europe and to seek FDA approval in the US.


Max Hodak’s Science raises $400m to take its sight-restoring chip to the US

Science CEO Max Hodak on Centre Stage at Web Summit 2025 in Lisbon

Image Credits Credit: Paul Devlin/Web Summit via Sportsfile / CC BY 4.0 via Flickr (cropped)

Science Corporation, the brain-computer interface company founded by former Neuralink president Max Hodak, has raised a $400m Series D. The round values it at $3.5bn, a person familiar with the deal told TechCrunch.

Backers include Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare and Y Combinator, Science said in a blog post. It has now raised more than $900m since 2021.

PRIMA, from Europe to the US

Science’s first product, PRIMA, is a wearable and implantable chip for people with age-related macular degeneration. Science says it is the first brain-computer interface with a CE mark to restore “form vision”. That is the ability to read letters, numbers and words.

The round comes a few months after PRIMA’s launch in Europe, where it is available in Germany. Science will use the money to make PRIMA available across more of Europe and to prepare a US launch.

In the US, Science is seeking FDA approval through the Humanitarian Device Exemption, a route for rare conditions. It persuaded the FDA that advanced macular degeneration in both eyes is uncommon enough to qualify, TechCrunch reported. Science is also testing PRIMA in patients with Stargardt disease, another cause of blindness.

Neurons on a chip

Science will also spend more on its biohybrid programme. It is a neural interface that joins engineered neurons to the brain’s own circuits. It is designing the first human trials with Yale neurosurgery professor Murat Günel, TechCrunch reported.

Hodak co-founded Neuralink in 2016 and was its president for four years before starting Science. The new money will also expand Science’s research, manufacturing and operations.

Other brain-interface startups have raised smaller rounds. Bridge Neurotech raised $13.5m in October for an ultrasound-based interface. In Europe, Barcelona’s INBRAIN Neuroelectronics is developing graphene brain implants.

Get the TNW newsletter

Get the most important tech news in your inbox each week.

Thanks! Check your inbox to confirm your subscription.

By subscribing you agree to our Privacy Statement.

Published
Back to top